KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Deferred Taxes (2016 - 2025)

Cme (CME) has disclosed Deferred Taxes for 17 consecutive years, with $21.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Deferred Taxes rose 147.87% to $21.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$6.1 million, a 90.81% increase, with the full-year FY2025 number at -$6.1 million, up 90.81% from a year prior.
  • Deferred Taxes was $21.3 million for Q4 2025 at Cme, up from -$6.7 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $27.0 million in Q2 2021 to a low of -$49.2 million in Q4 2023.
  • A 5-year average of -$6.8 million and a median of -$7.4 million in 2024 define the central range for Deferred Taxes.
  • Peak YoY movement for Deferred Taxes: soared 317.74% in 2021, then plummeted 4372.73% in 2023.
  • Cme's Deferred Taxes stood at $21.0 million in 2021, then plummeted by 105.24% to -$1.1 million in 2022, then tumbled by 4372.73% to -$49.2 million in 2023, then grew by 9.55% to -$44.5 million in 2024, then skyrocketed by 147.87% to $21.3 million in 2025.
  • Per Business Quant, the three most recent readings for CME's Deferred Taxes are $21.3 million (Q4 2025), -$6.7 million (Q3 2025), and -$13.3 million (Q2 2025).